Patients Got Unapproved Ebola Virus Drug

Published: Aug 06, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An Ebola drug developed by a company with just nine employees has been used to treat two infected Americans who recently have shown signs of improvement. The treatment, developed by Mapp Biopharmaceutical Inc., a closely-held company based in San Diego, was given to Kent Brantly and Nancy Writebol, both of whom were infected while working with aid groups in Liberia, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, in a telephone interview.

Help employers find you! Check out all the jobs and post your resume.

Back to news